JP2023512783A5 - - Google Patents

Info

Publication number
JP2023512783A5
JP2023512783A5 JP2022547874A JP2022547874A JP2023512783A5 JP 2023512783 A5 JP2023512783 A5 JP 2023512783A5 JP 2022547874 A JP2022547874 A JP 2022547874A JP 2022547874 A JP2022547874 A JP 2022547874A JP 2023512783 A5 JP2023512783 A5 JP 2023512783A5
Authority
JP
Japan
Application number
JP2022547874A
Other languages
Japanese (ja)
Other versions
JP2023512783A (ja
JP7804582B2 (ja
JPWO2021159092A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017113 external-priority patent/WO2021159092A1/en
Publication of JP2023512783A publication Critical patent/JP2023512783A/ja
Publication of JP2023512783A5 publication Critical patent/JP2023512783A5/ja
Publication of JPWO2021159092A5 publication Critical patent/JPWO2021159092A5/ja
Priority to JP2025138630A priority Critical patent/JP2025166240A/ja
Application granted granted Critical
Publication of JP7804582B2 publication Critical patent/JP7804582B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022547874A 2020-02-08 2021-02-08 ポンペ病を処置するための組成物および方法 Active JP7804582B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138630A JP2025166240A (ja) 2020-02-08 2025-08-22 ポンペ病を処置するための組成物および方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062971930P 2020-02-08 2020-02-08
US62/971,930 2020-02-08
US202063115975P 2020-11-19 2020-11-19
US63/115,975 2020-11-19
PCT/US2021/017113 WO2021159092A1 (en) 2020-02-08 2021-02-08 Compositions and methods for treating pompe disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138630A Division JP2025166240A (ja) 2020-02-08 2025-08-22 ポンペ病を処置するための組成物および方法

Publications (4)

Publication Number Publication Date
JP2023512783A JP2023512783A (ja) 2023-03-29
JP2023512783A5 true JP2023512783A5 (https=) 2024-02-16
JPWO2021159092A5 JPWO2021159092A5 (https=) 2024-02-16
JP7804582B2 JP7804582B2 (ja) 2026-01-22

Family

ID=74853758

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022547874A Active JP7804582B2 (ja) 2020-02-08 2021-02-08 ポンペ病を処置するための組成物および方法
JP2025138630A Pending JP2025166240A (ja) 2020-02-08 2025-08-22 ポンペ病を処置するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138630A Pending JP2025166240A (ja) 2020-02-08 2025-08-22 ポンペ病を処置するための組成物および方法

Country Status (12)

Country Link
US (2) US12251430B2 (https=)
EP (1) EP4100120A1 (https=)
JP (2) JP7804582B2 (https=)
KR (1) KR20220139936A (https=)
CN (1) CN115715218A (https=)
AU (1) AU2021216055A1 (https=)
BR (1) BR112022015505A2 (https=)
CA (1) CA3167091A1 (https=)
IL (1) IL295415A (https=)
MX (1) MX2022009753A (https=)
WO (1) WO2021159092A1 (https=)
ZA (1) ZA202209925B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021216055A1 (en) 2020-02-08 2022-09-29 Genzyme Corporation Compositions and methods for treating pompe disease
MX2022016019A (es) 2020-06-14 2023-04-10 Genzyme Corp Composiciones y metodos para el tratamiento de enfermedad de pompe de inicio tardio.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
EP1877099B1 (en) 2005-04-06 2012-09-19 Genzyme Corporation Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
SI2457920T1 (en) 2007-01-18 2018-02-28 Genzyme Corporation Oligosaccharides containing the amino acid group and their conjugates
CA3040973A1 (en) * 2008-12-16 2010-07-01 Genzyme Corporation Oligosaccharide-protein conjugates
CN110124039A (zh) 2011-05-16 2019-08-16 建新公司 使用甲氨蝶呤诱导免疫耐受性
US10172924B2 (en) * 2015-03-19 2019-01-08 Translate Bio, Inc. MRNA therapy for pompe disease
KR102510941B1 (ko) * 2015-12-30 2023-03-20 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병 치료용의 강화된 산 알파-글루코시다제
AU2021216055A1 (en) 2020-02-08 2022-09-29 Genzyme Corporation Compositions and methods for treating pompe disease

Similar Documents

Publication Publication Date Title
JP2023512783A5 (https=)
CN305748206S (https=)
CN305536972S (https=)
CN305855210S (https=)
CN305854319S (https=)
CN305852995S (https=)
CN305837916S (https=)
CN305837529S (https=)
CN305836075S (https=)
CN305834056S (https=)
CN305832889S (https=)
CN305831517S (https=)
CN305830841S (https=)
CN305786545S (https=)
CN305785253S (https=)
CN305784630S (https=)
CN305782749S (https=)
CN305779420S (https=)
CN305986998S (https=)
CN305536556S (https=)
CN305536207S (https=)
CN305536166S (https=)
CN305535914S (https=)
CN305534857S (https=)
CN305534141S (https=)